Business
Currency:USD
2023/FY
Stock NameRevenueRatio
Product revenue, net100.95M68.32%
Drug product revenue, net18.75M12.69%
Development and other revenue18.4M12.45%
License revenue9.65M6.53%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
China109.38M74.03%
Japan15.87M10.74%
United States12.96M8.77%
Europe9.55M6.46%
